G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 24,600 shares at $65.90 ($1.7M) on 2019-01-08, disclosed to the SEC on 2019-01-09.
Seasonal sale ($1.7M) by CFO — this insider has traded GHDX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.87 | 2,100 | $138K | 8.4% |
| 2 | $65.90 | 1,100 | $72K | 4.4% |
| 3 | $66.67 | 3,428 | $229K | 13.8% |
| 4 | $66.67 | 3,428 | $229K | 13.8% |
| 5 | $66.68 | 1,700 | $113K | 6.9% |
| 6 | $66.68 | 1,700 |
| $113K |
| 6.9% |
| 7 | $67.85 | 4,472 | $303K | 18.4% |
| 8 | $67.85 | 4,472 | $303K | 18.4% |
| 9 | $67.86 | 2,200 | $149K | 9.0% |
| Total | $67.10 avg | 24,600 | $1.7M | 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |